Financing type:  underwritten prospectus offering

Gross proceeds:  $40,651,260 (including the gross proceeds from the full exercise of the overallotment option)

Offering:  37,526,800 non-flow-through shares; 3.76 million charity flow-through shares

Offering price:  95 cents per non-flow-through share; $1.33 per charity flow-through share

Overallotment option:  The agent may purchase a maximum of 4,894,800 non-flow-through shares for overallotment purposes. As of the bulletin date, this option has been exercised and the aforementioned 4,894,800 non-flow-through shares have been issued thereunder. All information presented herein includes the effect of such exercise.

Commissions in securities:  nil

Disclosure:  Refer to the company's prospectus supplement dated Sept. 17, 2025, to the short form base shelf prospectus dated April 30, 2024, and the company's news releases dated Sept. 15, 2025, Sept. 16, 2025, Sept. 23, 2025, and Oct. 7, 2025.